JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB113849

Luminescent ATP Detection Assay Kit

5

(6 Reviews)

|

(284 Publications)

Luminescent ATP Detection Assay Kit (ab113849) measures the level of ATP within cultured cells as part of a cell viability or cytotoxicity assay. Cells are lysed, and then the luciferase-luciferin reaction is used to quantify the amount of ATP.

- Results in less than 30 minutes
- Simple protocol with just 2 reagent addition / incubation steps
- Wide linear dynamic range from less than 0.001 µM to 10 µM of ATP, and a 1 pM detection limit
- Cited in > 200 publications
5 Images
Functional Studies (Act) - Luminescent ATP Detection Assay Kit (AB113849)
  • FuncS (Act)

Unknown

Functional Studies (Act) - Luminescent ATP Detection Assay Kit (AB113849)

Simultaneous quantification of mitochondrial respiration and glycolytic flux.

Cellular Energy Flux for HepG2 cells (seeded at 65,000 per well), treated with a combination of drug compounds modulating the ETC (Antimycin A [1 μM] and FCCP [2.5 μM]), shown as a percentage relative to untreated control cells. Comparative measurements were taken with Extracellular Oxygen Consumption Assay (ab197243) (white column) and Glycolysis Assay [Extracellular acidification] (ab197244) (black column) show the shift between mitochondrial respiration and glycolysis and the cellular control of energy (ATP; measured 1h post-treatment using Luminescent ATP Detection Assay kit (ab113849) (striped column)).

Functional Studies (Act) - Luminescent ATP Detection Assay Kit (AB113849)
  • FuncS (Act)

Unknown

Functional Studies (Act) - Luminescent ATP Detection Assay Kit (AB113849)

Example of ATP standard curve using an opaque white plate.

The ATP standard curve was prepared as described in the protocol. Background-subtracted data values (mean +/- SD) are graphed.

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)
  • FuncS

Unknown

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)

Total cellular ATP concentration. ATP in SH-SY5Y cells cultivated at 21% and 5% O2 24 h after treatment with Aβ peptide and/or 18 h X-ray irradiation, normalized to cell count, and compared to respective controls. ATP concentration was about 1.3- to 1.8-fold higher at all conditions in cells cultivated at 5% O2 compared to 21% O2. Combination of Aβ peptide treatment and irradiation resulted in a significantly increased (~1.5-fold) ATP concentration at 5% O2 compared to the control. Samples were measured at least in duplicates (n = 2–4) in three independent experiments (N = 3). Mean ± SEM analyzed by two-way ANOVA with Tukey's multiple comparison test with p < 0.05 considered as significant. (∗∗ p < 0.01).

Dzinic, Tamara and Norbert A Dencher., Oxidative medicine and cellular longevity-vol. 2018 7567959., Fig 6, doi:10.1155/2018/7567959

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)
  • FuncS

AbReview61012****

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)

Extracellular detection of ATP.

Analysis of the release of ATP by connexin hemichannels in stem cells using ATP luminescence kit (ab113849).

Cells were cultured in HBSS to induce hemichannel opening. Calcium and GAP-inhibitor were used to trigger hemichannel closure.
After two hours the supernatant was collected and ATP was measured according to the protocol (detergent was also applied).

Calcium treatment and inhibition by GAP decreased ATP concentration, compared to HBSS control. Graph shows data of three independent experiments.

This image is courtesy of an Abreview submitted by Heiko Lemcke.

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)
  • FuncS

Supplier Data

Functional Studies - Luminescent ATP Detection Assay Kit (AB113849)

ab113849 ATP detection kit cytotoxicity data. 25000 HepG2 cells were seeded into each well, allowed to adhere and treated for 4 hours with 25µM rotenone and vehicle control (DMSO) in glucose based complete media. After treatment, cells were lysed, exposed to the ATP substrate solution and signal was measured on a luminescent counter. Mean and standard deviation is plotted for 3 replicates from each condition. Rotenone induces cytotoxicity in HepG2 cells.

Key facts

Detection method

Luminescent

Sample types

Suspension cells, Adherent cells

Results type

Quantitative

Assay time

30m

Assay Platform

Microplate reader

Product details

How the assay works

The luminescent ATP assay protocol involves lysis of the cell sample, addition of luciferase enzyme and luciferin, and measurement of the emitted light using a tube or microplate-based luminometer.

This kit irreversibly inactivates ATP degrading enzymes (ATPases) during the lysis step, ensuring that the luminescent signal obtained truly corresponds to the endogenous levels of ATP.

Luminescent ATP assay protocol summary:

- Add ATP standard into standard wells and media into control wells in same plate containing cells to be analyzed
- Add detergent solution and incubate for 5 min to lyse cells and stabilize ATP
- Add substrate solution and incubate for 5 min
- Store plate in dark for 10 min
- Analyze on luminescence plate reader

Special Handling Instructions for the ATP Detection Assay Kit

ATP can be found in cells and microbiota on many surfaces. To prevent unintended background, it is recommended to clean bench surfaces and all pipettes to be used during the experiment with 10% bleach. Use of gloves first cleaned by either using 70% ethanol or by changing them frequently is recommended. Use tips and containers that are clean and sterile, such as ATP and nuclease-free consumables. Do not leave reagents or the plate opened while working or during assay incubation

Related and recommended products

We also offer a very popular alternative colorimetric/fluorometric ATP assay kit ab83355 based on the phosphorylation of glycerol.

How other researchers are using

Luminescent ATP Detection Assay Kit has been used in a variety of sample type including:
HeLa cells 1
Mouse microglia cells 2
Rat ventricular cardiomyoblasts 3
References:

1-Sittewelle M et al. 2023
2-Sabogal-Guбqueta A et al. 2023
3-Gurler B et al. 2023

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "300Test": { "sellingSize": "300 Test", "publicAssetCode":"ab113849-300Test", "assetComponentDetails": [ { "size":"3 x 1 Vial", "name":"Lyophilized substrate", "number":"AB113849-CMP04", "productcode":"" }, { "size":"1 x 20 mL", "name":"Detergent", "number":"AB113849-CMP02", "productcode":"" }, { "size":"1 x 20 mL", "name":"Substrate Buffer", "number":"AB113849-CMP01", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Lyophilized ATP standard", "number":"AB113849-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ATP or adenosine triphosphate acts mechanically as the key energy carrier in cellular processes. It has a molecular mass of approximately 507 Da. ATP is present throughout prokaryotic and eukaryotic cells particularly in the cytoplasm mitochondria and chloroplasts. Known also as the "molecular unit of currency" ATP transfers energy for all biochemical reactions and cellular activities. ATP functions in various cellular activities including active transport across membranes signal transduction and muscle contraction.
Biological function summary

ATP provides the energy necessary for most cellular functions. It is part of the ATP synthesis complex also known as ATP synthase localized in the mitochondrial inner membrane (in eukaryotes) and the plasma membrane (in prokaryotes). This complex facilitates ATP production through oxidative phosphorylation. ATP also plays a significant role in cellular metabolism and energy transfer. Many enzymes use ATP to catalyze reactions converting ATP to ADP and inorganic phosphate releasing energy to power cellular activities.

Pathways

ATP is integral to both glycolysis and the citric acid cycle. In glycolysis ATP participates in substrate-level phosphorylation transferring energy from glucose breakdown steps. The citric acid cycle further processes metabolic intermediates generating high-energy electron carriers that feed the electron transport chain. This chain leads to ATP production via oxidative phosphorylation. ATP interacts with enzymes like hexokinase and phosphofructokinase in glycolysis and other enzymes in the electron transport chain like cytochrome c oxidase.

ATP's role is linked to various conditions such as mitochondrial diseases and cardiac ischemia. In mitochondrial diseases mutations in mitochondrial DNA affect ATP production leading to energy deficits in cells. These disorders involve proteins like NADH dehydrogenase a component of the mitochondrial respiratory chain. In cardiac ischemia reduced oxygen supply impairs ATP synthesis affecting heart muscle contraction. Ischemia involves proteins such as creatine kinase which buffers ATP levels to sustain cellular energy during reduced blood flow.

Product protocols

Publications (284)

Recent publications for all applications. Explore the full list and refine your search

JCI insight 10: PubMed40553569

2025

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Keisuke Shigeta,Tatsuaki Daimon,Hiroshi Hongo,Sheng-Yu Ku,Hiroki Ozawa,Naoki Haratake,Atsushi Fushimi,Ayako Nakashoji,Atrayee Bhattacharya,Shinkichi Takamori,Michihisa Kono,Masahiro Rokugo,Yuto Baba,Takeo Kosaka,Mototsugu Oya,Justine Jacobi,Mark D Long,Himisha Beltran,Donald Kufe

Nature communications 16:4414 PubMed40360510

2025

ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213.

Applications

Unspecified application

Species

Unspecified reactive species

Juraj Ahel,Arda Balci,Victoria Faas,Daniel B Grabarczyk,Roosa Harmo,Daniel R Squair,Jiazhen Zhang,Elisabeth Roitinger,Frederic Lamoliatte,Sunil Mathur,Luiza Deszcz,Lillie E Bell,Anita Lehner,Thomas L Williams,Hanna Sowar,Anton Meinhart,Nicola T Wood,Tim Clausen,Satpal Virdee,Adam J Fletcher

British journal of pharmacology 182:3923-3951 PubMed40344208

2025

A mitochondria-targeting and G-quadruplex structure-binding ligand inducing calcium overload and ferroptosis in human cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bo-Xin Zheng,Wei Long,Yao-Xun Zeng,Meng-Ting She,Yingying Zheng,Wen-De Zheng,Ya-Kun Wang,Ka-Hin Chan,Alan Siu-Lun Leung,Chun-Ming Chan,Yu-Jing Lu,Wing-Leung Wong

Purinergic signalling : PubMed40238052

2025

Involvement of purinergic signalling in the vasomotor response to hypochlorous acid in porcine coronary artery.

Applications

Unspecified application

Species

Unspecified reactive species

Ashwaq Baghdadi,William R Dunn,Vera Ralevic

Journal of molecular neuroscience : MN 75:46 PubMed40199799

2025

Fucoxanthinol Mitigates the Cytotoxic Effect of Chlorpyrifos and MPTP on the Dopaminergic Differentiation of SH-SY5Y Human Neuroblastoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ekramy M Elmorsy,Ayat B Al-Ghafari,Huda A Al Doghaither,Mona M Elghareeb,Mouhamed Alsaqati

Molecular therapy. Methods & clinical development 32:101347 PubMed39823061

2025

Design and validation of cell-based potency assays for frataxin supplementation treatments.

Applications

Unspecified application

Species

Unspecified reactive species

Shibani Mukherjee,Larisa Pereboeva,Daniel Fil,Achisha Saikia,Jeon Lee,Jixue Li,M Grazia Cotticelli,Elisabetta Soragni,Robert B Wilson,Marek Napierala,Jill S Napierala

Nanomaterials (Basel, Switzerland) 14: PubMed39728553

2024

Pleozymes: Pleiotropic Oxidized Carbon Nanozymes Enhance Cellular Metabolic Flexibility.

Applications

Unspecified application

Species

Unspecified reactive species

Anh T T Vo,Karthik Mouli,Anton V Liopo,Philip Lorenzi,Lin Tan,Bo Wei,Sara A Martinez,Emily A McHugh,James M Tour,Uffaf Khan,Paul J Derry,Thomas A Kent

Journal of nanobiotechnology 22:740 PubMed39609811

2024

Oral creatine-modified selenium-based hyaluronic acid nanogel mediated mitochondrial energy recovery to drive the treatment of inflammatory bowel disease.

Applications

Unspecified application

Species

Unspecified reactive species

Manxiu Huai,Mingliang Pei,Jie Chen,Xiaoyan Duan,Yun Zhu,Fan Yang,Wensong Ge

Nature communications 15:9380 PubMed39477919

2024

A wearable and stretchable dual-wavelength LED device for home care of chronic infected wounds.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Li,Chenxi Wang,Qiang Yu,Haoyi Chen,Yingying Ma,Li Wei,Mei X Wu,Min Yao,Min Lu

Cell communication and signaling : CCS 22:485 PubMed39390438

2024

Loss of mitochondrial Ca response and CaMKII/ERK activation by LRRK2 mutation correlate with impaired depolarization-induced mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Eunice Eun-Seo Chang,Huifang Liu,Zoe Yuen-Kiu Choi,Yasine Malki,Steffi Xi-Yue Zhang,Shirley Yin-Yu Pang,Michelle Hiu-Wai Kung,David B Ramsden,Shu-Leong Ho,Philip Wing-Lok Ho
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com